106 related articles for article (PubMed ID: 35434902)
1. Microwave focal therapy of prostate cancer: a non-clinical study and exploratory clinical trial.
Boku H; Kaneko M; Yamada Y; Morinaga Y; Konishi E; Uno A; Ito-Ihara T; Yamada A; Horiguchi G; Teramukai S; Fujihara A; Shiraishi T; Yamada T; Ueda T; Matsugasumi T; Ohashi M; Horiuchi D; Inoue Y; Ukimura O
BJU Int; 2022 Dec; 130(6):776-785. PubMed ID: 35434902
[TBL] [Abstract][Full Text] [Related]
2. Magnetic resonance guided focused high frequency ultrasound ablation for focal therapy in prostate cancer - phase 1 trial.
Ghai S; Perlis N; Lindner U; Hlasny E; Haider MA; Finelli A; Zlotta AR; Kulkarni GS; van der Kwast TH; McCluskey SA; Kucharczyk W; Trachtenberg J
Eur Radiol; 2018 Oct; 28(10):4281-4287. PubMed ID: 29696431
[TBL] [Abstract][Full Text] [Related]
3. Focal therapy for localised unifocal and multifocal prostate cancer: a prospective development study.
Ahmed HU; Hindley RG; Dickinson L; Freeman A; Kirkham AP; Sahu M; Scott R; Allen C; Van der Meulen J; Emberton M
Lancet Oncol; 2012 Jun; 13(6):622-32. PubMed ID: 22512844
[TBL] [Abstract][Full Text] [Related]
4. Magnetic resonance imaging-guided transurethral ultrasound ablation in patients with localised prostate cancer: 3-year outcomes of a prospective Phase I study.
Nair SM; Hatiboglu G; Relle J; Hetou K; Hafron J; Harle C; Kassam Z; Staruch R; Burtnyk M; Bonekamp D; Schlemmer HP; Roethke MC; Mueller-Wolf M; Pahernik S; Chin JL
BJU Int; 2021 May; 127(5):544-552. PubMed ID: 33037765
[TBL] [Abstract][Full Text] [Related]
5. Prostate Radiofrequency Focal Ablation (ProRAFT) Trial: A Prospective Development Study Evaluating a Bipolar Radiofrequency Device to Treat Prostate Cancer.
Orczyk C; Barratt D; Brew-Graves C; Peng Hu Y; Freeman A; McCartan N; Potyka I; Ramachandran N; Rodell R; Williams NR; Emberton M; Ahmed HU
J Urol; 2021 Apr; 205(4):1090-1099. PubMed ID: 33315505
[TBL] [Abstract][Full Text] [Related]
6. Phase I study of cancer lesion-targeted microwave coagulation therapy for localized prostate cancer: A pilot clinical study protocol.
Yamada Y; Shiaishi T; Ueno A; Kaneko M; Inoue Y; Fujihara A; Hongo F; Ukimura O
Contemp Clin Trials Commun; 2019 Dec; 16():100471. PubMed ID: 31701044
[TBL] [Abstract][Full Text] [Related]
7. Magnetic Resonance Imaging-Guided Transurethral Ultrasound Ablation of Prostate Tissue in Patients with Localized Prostate Cancer: A Prospective Phase 1 Clinical Trial.
Chin JL; Billia M; Relle J; Roethke MC; Popeneciu IV; Kuru TH; Hatiboglu G; Mueller-Wolf MB; Motsch J; Romagnoli C; Kassam Z; Harle CC; Hafron J; Nandalur KR; Chronik BA; Burtnyk M; Schlemmer HP; Pahernik S
Eur Urol; 2016 Sep; 70(3):447-55. PubMed ID: 26777228
[TBL] [Abstract][Full Text] [Related]
8. Magnetic resonance image-guided focal laser ablation in clinically localized prostate cancer: safety and efficacy.
Al-Hakeem Y; Raz O; Gacs Z; Maclean F; Varol C
ANZ J Surg; 2019 Dec; 89(12):1610-1614. PubMed ID: 31679182
[TBL] [Abstract][Full Text] [Related]
9. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
10. Magnetic resonance imaging-transrectal ultrasound fusion focal cryotherapy of the prostate: A prospective development study.
Valerio M; Shah TT; Shah P; Mccartan N; Emberton M; Arya M; Ahmed HU
Urol Oncol; 2017 Apr; 35(4):150.e1-150.e7. PubMed ID: 27955940
[TBL] [Abstract][Full Text] [Related]
11. Prostate cancer treatment by the latest focal HIFU device with MRI/TRUS-fusion control biopsies: A prospective evaluation.
von Hardenberg J; Westhoff N; Baumunk D; Hausmann D; Martini T; Marx A; Porubsky S; Schostak M; Michel MS; Ritter M
Urol Oncol; 2018 Sep; 36(9):401.e1-401.e9. PubMed ID: 30093211
[TBL] [Abstract][Full Text] [Related]
12. Focal Laser Ablation of Prostate Cancer: Phase I Clinical Trial.
Natarajan S; Raman S; Priester AM; Garritano J; Margolis DJ; Lieu P; Macairan ML; Huang J; Grundfest W; Marks LS
J Urol; 2016 Jul; 196(1):68-75. PubMed ID: 26748164
[TBL] [Abstract][Full Text] [Related]
13. Safety and Feasibility of Transperineal Targeted Microwave Ablation for Low- to Intermediate-risk Prostate Cancer.
Oderda M; Marquis A; Calleris G; D'Agate D; Faletti R; Gatti M; Marra G; Gontero P
Eur Urol Open Sci; 2022 Dec; 46():3-7. PubMed ID: 36304751
[TBL] [Abstract][Full Text] [Related]
14. Feasibility of MRI-guided transurethral ultrasound for lesion-targeted ablation of prostate cancer.
Anttinen M; Mäkelä P; Suomi V; Kiviniemi A; Saunavaara J; Sainio T; Horte A; Eklund L; Taimen P; Sequeiros RB; Boström PJ
Scand J Urol; 2019 Oct; 53(5):295-302. PubMed ID: 31556779
[No Abstract] [Full Text] [Related]
15. Novel Automated Three-Dimensional Surgical Planning Tool and Magnetic Resonance Imaging/Ultrasound Fusion Technology to Perform Nanoparticle Ablation and Cryoablation of the Prostate for Focal Therapy.
Jue JS; Coons S; Hautvast G; Thompson SF; Geraats J; Richstone L; Schwartz MJ; Rastinehad AR
J Endourol; 2022 Mar; 36(3):369-372. PubMed ID: 34409850
[No Abstract] [Full Text] [Related]
16. Nanoknife Electroporation Ablation Trial: A Prospective Development Study Investigating Focal Irreversible Electroporation for Localized Prostate Cancer.
Valerio M; Dickinson L; Ali A; Ramachadran N; Donaldson I; Mccartan N; Freeman A; Ahmed HU; Emberton M
J Urol; 2017 Mar; 197(3 Pt 1):647-654. PubMed ID: 27697580
[TBL] [Abstract][Full Text] [Related]
17. Feasibility and safety of targeted focal microwave ablation of the index tumor in patients with low to intermediate risk prostate cancer: Results of the FOSTINE trial.
Barry Delongchamps N; Schull A; Anract J; Abecassis JP; Zerbib M; Sibony M; Jilet L; Abdoul H; Goffin V; Peyromaure M
PLoS One; 2021; 16(7):e0252040. PubMed ID: 34260598
[TBL] [Abstract][Full Text] [Related]
18. Risk-stratification based on magnetic resonance imaging and prostate-specific antigen density may reduce unnecessary follow-up biopsy procedures in men on active surveillance for low-risk prostate cancer.
Alberts AR; Roobol MJ; Drost FH; van Leenders GJ; Bokhorst LP; Bangma CH; Schoots IG
BJU Int; 2017 Oct; 120(4):511-519. PubMed ID: 28267899
[TBL] [Abstract][Full Text] [Related]
19. Percutaneous transperineal radiofrequency ablation of prostate tumour: safety, feasibility and pathological effects on human prostate cancer.
Zlotta AR; Djavan B; Matos C; Noel JC; Peny MO; Silverman DE; Marberger M; Schulman CC
Br J Urol; 1998 Feb; 81(2):265-75. PubMed ID: 9488071
[TBL] [Abstract][Full Text] [Related]
20. Phase II Evaluation of Magnetic Resonance Imaging Guided Focal Laser Ablation of Prostate Cancer.
Eggener SE; Yousuf A; Watson S; Wang S; Oto A
J Urol; 2016 Dec; 196(6):1670-1675. PubMed ID: 27449263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
